期刊文献+

基于代谢组学的胃癌组织和血浆的糖代谢研究 被引量:3

Study on Saccharometabolism of Gastric Cancer Tissues and Plasma Based upon Metabolomics
下载PDF
导出
摘要 背景:肿瘤细胞糖酵解明显增强,但糖酵解对机体全身代谢的影响尚不明确。目的:研究胃癌患者组织和血浆的糖代谢中间产物变化,以建立胃癌局部代谢与机体全身代谢的联系。方法:收集20份慢性胃炎组织、17份胃癌组织、15份慢性胃炎血浆、15份胃癌血浆和15份胃癌术后血浆样本,应用气相色谱-飞行时间质谱(GC-TOFMS)方法检测糖代谢中间产物的变化。结果:共鉴定出13种糖代谢中间产物。与慢性胃炎组织相比,胃癌组织中麦芽糖、葡萄糖、甲基β-D-吡喃葡萄糖苷、6-磷酸果糖、核糖浓度明显降低而乳糖、乳酸、柠檬酸浓度明显升高(P<0.05)。与慢性胃炎血浆相比,胃癌血浆葡萄糖、乳酸、琥珀酸、延胡索酸和苹果酸浓度明显降低而蔗糖、甲基β-D-吡喃葡萄糖苷浓度明显升高(P<0.05)。与胃癌血浆相比,胃癌术后血浆蔗糖、半乳糖酸内酯、甲基β-D-吡喃葡萄糖苷浓度明显降低而葡萄糖、乳酸、柠檬酸、琥珀酸、延胡索酸、苹果酸明显升高(P<0.05)。结论:胃癌组织存在糖酵解、三羧酸循环代谢异常,并对全身代谢产生了影响。基于GC-TOFMS的代谢组学是研究胃癌代谢轮廓的合适平台。 Background: Glycolysis is significantly elevated in tumor cells, but the effect of glycolysis on systemic metabolism is still unclear. Aims: To investigate the changes of saccharometabolism intermediates in tissues and plasma of patients with gastric cancer (GC) in order to establish the link between local metabolism of tumor and systemic metabolism. Methods: Eighty-two samples including 20 chronic superficial gastritis (CSG) tissue samples, 17 GC tissue samples, 15 CSG plasma samples, 15 GC plasma samples and 15 postoperative GC plasma samples were collected. Changes of saccharometabolism intermediates were detected by gas chromatography-time of flight mass spectrometry (GC-TOFMS) technique. Results: A total of 13 saccharometabolism intermediates were identified. Compared with CSG tissues, maltose, glucose, methyl β-D-glucopyranoside, fructose-6-phosphate and ribose decreased significantly while lactose, lactic acid and citric acid increased significantly in GC tissues (P〈0.05). Compared with CSG plasma, glucose, lactic acid, succinic acid, fumaric acid and malic acid decreased significantly while sucrose and methyl ~3-D-glucopyranoside increased significantly in GC plasma (P〈0.05). Compared with GC plasma, sucrose, L-galaetono-l,4-1actone and methyl β-D- glucopyranoside decreased significantly while glucose, lactic acid, citric acid, suceinic acid, fumaric acid and malic acid increased significantly in postoperative GC plasma (P〈0.05). Conclusions: This study demonstrates that there is a metabolic dysregulation of glycolysis and tricarboxylic acid cycle in GC tissues, and it affects the systemic metabolism. GC-TOFMS-based metabolomics can be used as a suitable method for studying the metabolism of GC.
出处 《胃肠病学》 2011年第10期609-612,共4页 Chinese Journal of Gastroenterology
关键词 代谢组学 胃肿瘤 糖酵解 柠檬酸循环 Metabolomics Stomach Neoplasms Glycolysis Citric Acid Cycle
  • 相关文献

参考文献5

二级参考文献22

  • 1王启俊,祝伟星,袁光亮.2001年北京地区癌症死亡预测[J].中华流行病学杂志,1995,16(4):195-198. 被引量:6
  • 2[1]Meddings JB,Sutherland LR,Byles NI,Wallace JL.Sucrose:a novel permeability marker for gastroduodenal disease.Gastroenterology 1993; 104:1619-1926
  • 3[2]Sutherland LR,Verhoef M,Wallace JL,Van Rosendaal G,Crutcher R,Meddings JB.A simple,non-invasive marker of gastric damage:sucrose permeability.Lancet 1994; 343:998-1000
  • 4[3]Meddings JB,Kirk D,Olson ME.Noninvasive detection of nonsteroidal anti-inflammatory drug-induced gastropathy in dogs.Am J Vet Res 1995; 56:977-981
  • 5[4]Rabassa AA,Goodgame R,Sutton FM,Ou CN,Rognerud C,Graham DY.Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose.Gut 1996; 39:159-163
  • 6[5]Smecuol E,Bai JC,Sugai E,Vazquez H,Niveloni S,Pedreira S,Maurino E,Meddings J.Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.Gut 2001; 49:650-655
  • 7[6]Kiziltas S,Imeryuz N,Gurcan T,Siva A,Saip S,Dumankar A,Kalayci C,Ulusoy NB.Corticosteroid therapy augments gastroduodenal permeability to sucrose.Am J Gastroenterol1998; 93:2420-2425
  • 8[7]Goodgame RW,Malaty HM,el-Zimaity HM,Graham DY.Decrease in gastric permeability to sucrose following cure of Helicobacter pylori infection.Helicobacter 1997; 2:44-47
  • 9[8]Vogelsang H,Oberhuber G,Wyatt J.Lymphocytic gastritis and gastric permeability in patients with celiac disease.Gastroenterology 1996; 111:73-77
  • 10[9]Seimiya M,Osawa S,Hisae N,Shishido T,Yamaguchi T,Nomura F.A sensitive enzymatic assay for the determination of sucrose in serum and urine.Clin Chim Acta 2004; 343:195-199

共引文献348

同被引文献46

  • 1钦可为,韩超峰,Cheng J,Quintin RA,Cramer KM.有氧糖酵解是受训免疫的代谢基础[J].中国肿瘤生物治疗杂志,2015,22(2):176-176. 被引量:1
  • 2陈宏.MF-多源治疗仪促进术后胃肠功能恢复疗效观察[J].实用医院临床杂志,2007,4(5):82-82. 被引量:4
  • 3Renner C.Carnosine inhibits ATP production in cells from malignant glioma[J].Neurological Research,2010,32(1):101-105.
  • 4Haddad F,Ashley E;Michelakis ED.New insights for the diagnosis and management of right ventricular failure,from molecular imaging to targeted right ventricular therapy[J].Current opinion in cardiology,2010,25(2):131-140.
  • 5Rong,Cui,:Xing-Yao,Shi.Expression of pyruvate kinase M2in human colorectal cancer and its prognostic value[J].International journal of clinical and experimental pathology,2015,8(9):11393-9.
  • 6David Christensen,Philip C Calder,Franchesca D Houghton.GLUT3 and PKM2 regulate OCT4 expression and support the hypoxic culture of human embryonic stem cells[J].Scientific reports,2015,(5):17500.
  • 7Guanzhen Yu,Wenlong Yu,Guangzhi Jin,et al.PKM2regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma[J].Molecular cancer,2015,14(1):193.
  • 8Niki Karachaliou,Jordi Codony-Servat,Cristina Teixidó,et al.BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer[J].Scientific reports,2015,5:17499.
  • 9Jielai Yang,Dongdong Cheng,Shumin Zhou,et al.Overexpression of X-Box Binding Protein1(XBP1)Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma[J].International journal of molecular sciences,2015,16(12):28635-28646.
  • 10YuKai Wang,Fang Deng,Jing Miao,et al.Neuroprotection by Carbenoxolone Against Ischemia Injury Involves PI3K/Akt Pathway[J].Clinical laboratory,2015,61(10):1561-1568.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部